Ann Marie LeVine
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ann Marie LeVine has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Jeffrey A Whitsett
Division of Pulmonary Biology, Children’s Hospital Medical Center , Cincinnati, OH 45229
2 shared publicationsThomas R. Korfhagen
Division of Pulmonary Biology, Children’s Hospital Medical Center , Cincinnati, OH 45229
2 shared publicationsErika C. Crouch
Department of Pathology, Washington University School of Medicine , St. Louis, MO 63110
1 shared publicationJames H. Fisher
Division of Pulmonary Biology/Critical Care Medicine, University of Colorado , Denver, CO 80262
1 shared publicationJodie A Gwozdz
1 shared publication- Kevan L. Hartshorn
Boston University School of Medicine, Department of Medicine, Boston, MA, United States of America
1 shared publication
Latest Publications
- 15 November 2001
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 167 (10) , 5868-5873
Surfactant Protein D Enhances Clearance of Influenza A Virus from the Lung In Vivo
Mice lacking surfactant protein surfactant protein D (SP-D−/−) and wild-type mice (SP-D+/+) were infected with influenza A virus (IAV) by intranasal instillation. IAV infection increased the endogenous SP-D concentration in wild-type mice. SP-D-deficient mice showed decreased viral clearance of the Phil/82 strain of IAV and increased production of inflammatory cytokines in response to viral challenge. However, the less glycosylated strain of IAV, Mem/71, which is relatively resistant to SP-D in vitro, was cleared efficiently from the lungs of SP-D−/− mice. Viral clearance of the Phil/82 strain of IAV and the cytokine response were both normalized by the coadministration of recombinant SP-D. Since the airway is the usual portal of entry for influenza A virus and other respiratory pathogens, SP-D is likely to play an important role in innate defense responses to IAV.
- 15 November 2001
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 167 (10) , 5868-5873
Surfactant Protein D Enhances Clearance of Influenza A Virus from the Lung In Vivo
Mice lacking surfactant protein surfactant protein D (SP-D−/−) and wild-type mice (SP-D+/+) were infected with influenza A virus (IAV) by intranasal instillation. IAV infection increased the endogenous SP-D concentration in wild-type mice. SP-D-deficient mice showed decreased viral clearance of the Phil/82 strain of IAV and increased production of inflammatory cytokines in response to viral challenge. However, the less glycosylated strain of IAV, Mem/71, which is relatively resistant to SP-D in vitro, was cleared efficiently from the lungs of SP-D−/− mice. Viral clearance of the Phil/82 strain of IAV and the cytokine response were both normalized by the coadministration of recombinant SP-D. Since the airway is the usual portal of entry for influenza A virus and other respiratory pathogens, SP-D is likely to play an important role in innate defense responses to IAV.
- 1 October 2000
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 165 (7) , 3934-3940
Distinct Effects of Surfactant Protein A or D Deficiency During Bacterial Infection on the Lung
Mice lacking surfactant protein (SP)-A (SP-A−/−) or SP-D (SP-D−/−) and wild-type mice were infected with group B streptococcus or Haemophilus influenzae by intratracheal instillation. Although decreased killing of group B streptococcus and H. influenzae was observed in SP-A−/− mice but not in SP-D−/− mice, deficiency of either SP-A or SP-D was associated with increased inflammation and inflammatory cell recruitment in the lung after infection. Deficient uptake of bacteria by alveolar macrophages was observed in both SP-A- and SP-D-deficient mice. Isolated alveolar macrophages from SP-A−/− mice generated significantly less, whereas those from SP-D−/− mice generated significantly greater superoxide and hydrogen peroxide compared with wild-type alveolar macrophages. In SP-D−/− mice, bacterial killing was associated with increased lung inflammation, increased oxidant production, and decreased macrophage phagocytosis. In contrast, in the absence of SP-A, bacterial killing was decreased and associated with increased lung inflammation, decreased oxidant production, and decreased macrophage phagocytosis. Increased oxidant production likely contributes to effective bacterial killing in the lungs of SP-D−/− mice. The collectins, SP-A and SP-D, play distinct roles during bacterial infection of the lung.
- 1 October 2000
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 165 (7) , 3934-3940
Distinct Effects of Surfactant Protein A or D Deficiency During Bacterial Infection on the Lung
Mice lacking surfactant protein (SP)-A (SP-A−/−) or SP-D (SP-D−/−) and wild-type mice were infected with group B streptococcus or Haemophilus influenzae by intratracheal instillation. Although decreased killing of group B streptococcus and H. influenzae was observed in SP-A−/− mice but not in SP-D−/− mice, deficiency of either SP-A or SP-D was associated with increased inflammation and inflammatory cell recruitment in the lung after infection. Deficient uptake of bacteria by alveolar macrophages was observed in both SP-A- and SP-D-deficient mice. Isolated alveolar macrophages from SP-A−/− mice generated significantly less, whereas those from SP-D−/− mice generated significantly greater superoxide and hydrogen peroxide compared with wild-type alveolar macrophages. In SP-D−/− mice, bacterial killing was associated with increased lung inflammation, increased oxidant production, and decreased macrophage phagocytosis. In contrast, in the absence of SP-A, bacterial killing was decreased and associated with increased lung inflammation, decreased oxidant production, and decreased macrophage phagocytosis. Increased oxidant production likely contributes to effective bacterial killing in the lungs of SP-D−/− mice. The collectins, SP-A and SP-D, play distinct roles during bacterial infection of the lung.